Bio-engineered Stent Market - Global Industry Insights and Forecast, 2022 - 2028

Bio-engineered Stent Market - Global Industry Insights and Forecast, 2022 - 2028

Report Description
Bio-engineered stents consist of short narrow metal or plastic tube, which is used to treat blocked arteries. It is used by patients who are suffering from different types of cardiovascular diseases such as coronary heart disease and ischemic heart disease. Different types of bio-engineered stent are available in market for various diseases such as coronary artery disease, peripheral arterial disease, carotid artery disease, renal artery stenosis, abdominal aortic aneurysm, thoracic aortic aneurysm among others.
Market Dynamics
Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same source, cardiovascular diseases accounted for around 836,546 deaths in the U.S. in 2015, which accounted for around 1 in every 3 deaths.
Moreover, key players in the market are focused on adopting various strategies such as new Product Type launch and approvals and partnerships and collaborations to increase their foothold in the market. For instance, in May 2021, Medtronic plc., received the U.S. Food and Drug Administration (FDA) approval and Resolute Onyx, 4.5 MM and 5 mm sizes Drug-Eluting Stent. This device has proven clinical performance and superior deliverability of the Resolute Integrity. This device is intended to treat people with coronary artery disease in the U.S.
However, availability of alternatives for the treatment of cardiac diseases, Product Type recalls and failure, and stringent regulations for Product Type approvals are expected to hinder the market growth. For instance in November 2021, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, an absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent.
Key features of the study:
This report provides in-depth analysis of the bio-engineered stents market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global bio-engineered stents market based on the following parameters – company overview, financial performance, Product Type portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and Jotec GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Bio-engineered stents market report caters to various stakeholders in this industry including investors, suppliers, Product Type manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bio-engineered stents market
Detailed Segmentation:
Global Bio-engineered Stents Market, By Application Type:
Coronary artery disease
Peripheral arterial disease
Carotid Artery Disease
Renal Artery Stenosis
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Others
Global Bio-engineered Stents Market, By Product Type:
Drug-eluting Stents
Bioabsorbable Stents
Drug-eluting Balloons
Global Bio-engineered Stents Market, By Mode of Delivery:
Balloon-expandable Stents
Self-expanding Stents
Global Bio-engineered Stents Market, By Material Type:
Metal-based
Polymer-based
Global Bio-engineered Stents Market, By End User:
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others
Global Bio-engineered Stents Market, By Geography:
North America
By Application Type:
Coronary artery disease
Peripheral arterial disease
Carotid Artery Disease
Renal Artery Stenosis
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Others
By Product Type:
Drug-eluting Stents
Bioabsorbable Stents
Drug-eluting balloons
By Mode of Delivery:
Balloon-expandable Stents
Self-expanding Stents
By Material Type:
Metal-based
Polymer-based
By End User:
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others
By Country:
U.S.
Canada
Latin America
By Application Type:
Coronary artery disease
Peripheral arterial disease
Carotid Artery Disease
Renal Artery Stenosis
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Others
By Product Type:
Drug-eluting Stents
Bioabsorbable Stents
Drug-eluting balloons
By Mode of Delivery:
Balloon-expandable Stents
Self-expanding Stents
By Material Type:
Metal-based
Polymer-based
By End User:
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Application Type:
Coronary artery disease
Peripheral arterial disease
Carotid Artery Disease
Renal Artery Stenosis
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Others
By Product Type:
Drug-eluting Stents
Bioabsorbable Stents
Drug-eluting balloons
By Mode of Delivery:
Balloon-expandable Stents
Self-expanding Stents
By Material Type:
Metal-based
Polymer-based
By End User:
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Application Type:
Coronary artery disease
Peripheral arterial disease
Carotid Artery Disease
Renal Artery Stenosis
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Others
By Product Type:
Drug-eluting Stents
Bioabsorbable Stents
Drug-eluting balloons
By Mode of Delivery:
Balloon-expandable Stents
Self-expanding Stents
By Material Type:
Metal-based
Polymer-based
By End User:
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Application Type:
Coronary artery disease
Peripheral arterial disease
Carotid Artery Disease
Renal Artery Stenosis
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Others
By Product Type:
Drug-eluting Stents
Bioabsorbable Stents
Drug-eluting balloons
By Mode of Delivery:
Balloon-expandable Stents
Self-expanding Stents
By Material Type:
Metal-based
Polymer-based
By End User:
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Application Type:
Coronary artery disease
Peripheral arterial disease
Carotid Artery Disease
Renal Artery Stenosis
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Others
By Product Type:
Drug-eluting Stents
Bioabsorbable Stents
Drug-eluting balloons
By Mode of Delivery:
Balloon-expandable Stents
Self-expanding Stents
By Material Type:
Metal-based
Polymer-based
By End User:
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Medtronic, plc. *
Company Overview
Product Type Portfolio
Financial Performance
Key Highlights
Market Strategies
Boston Scientific Corporation
Abbott Laboratories
Biotronik SE & Co. KG
B. Braun Melsungen AG
Terumo Corporation
MicroPort Scientific Corporation
Stentys SA
Meril Life Sciences Pvt. Ltd
Vascular Concepts
W. L. Gore and Associates
C. R. Bard
Endologix, Inc.
Lombard Medical Technologies
Translumina GmbH
Jotec GmbH
“*” marked represents similar segmentation in other categories in the respective section.